Newsletter
Mark Cuban’s Cost Plus Drugs Is Solving the Equity Problem in Prescription Medicine

This Week In Health IT

Mark Cuban’s Cost Plus Drugs Is Solving the Equity Problem in Prescription Medicine

April 8, 2022

Mark Cuban’s Cost Plus Drugs Is Solving the Equity Problem in Prescription Medicine

April 8, 2022: Our guest today is Mark Cuban, American billionaire entrepreneur, television personality, media proprietor and the Founder of the Mark Cuban Cost Plus Drug Co. The drug industry is up against giant companies with lots of money and influence and complicated relationships with tentacles wrapped around government manufacturers, insurance companies, drug stores, pharmacists, retailers and more. There’s all kinds of super complicated contract arrangements that include rebates and hardwired incentives that keep this giant self-licking ice cream cone stuck together. The participants in this cartel like the deals they have and they make good money on them. The system is built to keep others out. But every American should have access to safe, affordable medicines. How is the Mark Cuban Cost Plus Drug Co disrupting this space?

Key Points:

  • We have one simple goal. To be the lowest cost provider of drugs. Period. End of story.
  • Patients want cheaper drugs. It makes their life easier. 
  • A red flag in the cost of healthcare in the US is the administrative costs
  • Mark Cuban Cost Plus Drug Co
  • Mark Cuban’s email: [email protected]

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Four Authors Untangle When Dad Has Dementia Virtual Q&A on the changes and challenges a dementia diagnosis.